These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
22. Imidazol-1-yl and pyridin-3-yl derivatives of 4-phenyl-1,4-dihydropyridines combining Ca2+ antagonism and thromboxane A2 synthase inhibition. Cozzi P; Carganico G; Fusar D; Grossoni M; Menichincheri M; Pinciroli V; Tonani R; Vaghi F; Salvati P J Med Chem; 1993 Oct; 36(20):2964-72. PubMed ID: 8411014 [TBL] [Abstract][Full Text] [Related]
23. Novel antiasthmatic agents with dual activities of thromboxane A2 synthetase inhibition and bronchodilation. 2. 4-(3-Pyridyl)-1(2H)-phthalazinones. Yamaguchi M; Kamei K; Koga T; Akima M; Maruyama A; Kuroki T; Ohi N J Med Chem; 1993 Dec; 36(25):4061-8. PubMed ID: 8258828 [TBL] [Abstract][Full Text] [Related]
24. Probing the stereointegrity of Tröger's base--a dynamic electrokinetic chromatographic study. Trapp O; Trapp G; Kong J; Hahn U; Vögtle F; Schurig V Chemistry; 2002 Aug; 8(16):3629-34. PubMed ID: 12203289 [TBL] [Abstract][Full Text] [Related]
25. (1)H and (13)C NMR studies of asymmetrically substituted bis- and tris-Tröger's bases. Elguero J; Fruchier A; Mas T; Pardo C Magn Reson Chem; 2005 Aug; 43(8):665-9. PubMed ID: 15986498 [TBL] [Abstract][Full Text] [Related]
26. Modular Synthesis of Optically Active Tröger's Base Analogues. Kamiyama T; Özer MS; Otth E; Deska J; Cvengroš J Chempluschem; 2013 Dec; 78(12):1510-1516. PubMed ID: 31986657 [TBL] [Abstract][Full Text] [Related]
27. 6,6-Disubstituted Hex-5-enoic acid derivatives as combined thromboxane A2 receptor antagonists and synthetase inhibitors. Soyka R; Heckel A; Nickl J; Eisert W; Müller TH; Weisenberger H J Med Chem; 1994 Jan; 37(1):26-39. PubMed ID: 8289199 [TBL] [Abstract][Full Text] [Related]
28. Thromboxane receptor antagonism combined with thromboxane synthase inhibition. 3. Pyridinylalkyl-substituted 8-[(arylsulfonyl)amino]octanoic acids. Main AJ; Bhagwat SS; Boswell C; Goldstein R; Gude C; Cohen DS; Furness P; Lee W; Louzan M J Med Chem; 1992 Nov; 35(23):4366-72. PubMed ID: 1447737 [TBL] [Abstract][Full Text] [Related]
30. A desymmetrization route to fused Troger's base analogues: synthesis, isolation, and characterization of the first anti-anti diastereomer of a fused tris-Troger's base analogue. Hansson A; Wixe T; Bergquist KE; Wärnmark K Org Lett; 2005 May; 7(10):2019-22. PubMed ID: 15876044 [TBL] [Abstract][Full Text] [Related]
31. Thromboxane receptor antagonism combined with thromboxane synthase inhibition. 2. Synthesis and biological activity of 8-(benzenesulfonamido)-7-(3-pyridinyl)octaonic acid and related compounds. Main AJ; Goldstein R; Cohen DS; Furness P; Lee W J Med Chem; 1992 Nov; 35(23):4362-5. PubMed ID: 1447736 [TBL] [Abstract][Full Text] [Related]
32. Thromboxane receptor antagonism combined with thromboxane synthase inhibition. 4. 8-[[(4-Chlorophenyl)sulfonyl]amino]-4-(3-(3-pyridinyl) propyl)octanoic acid and analogs. Bhagwat SS; Gude C; Boswell C; Contardo N; Cohen DS; Dotson R; Mathis J; Lee W; Furness P; Zoganas H J Med Chem; 1992 Nov; 35(23):4373-83. PubMed ID: 1447738 [TBL] [Abstract][Full Text] [Related]
33. Selective thromboxane synthetase inhibitors and antihypertensive agents. New derivatives of 4-hydrazino-5H-pyridazino[4,5-b]indole, 4-hydrazinopyridazino[4,5-a]indole, and related compounds. Monge A; Parrado P; Font M; Fernández-Alvarez E J Med Chem; 1987 Jun; 30(6):1029-35. PubMed ID: 3585901 [TBL] [Abstract][Full Text] [Related]
35. Characterization of microstructures and reaction mechanisms of Tröger's base polymers of intrinsic microporosity. Gies AP; Hefner RE; Rau NJ; Mukhopadhyay S; Reyes JCP; Herceg E Rapid Commun Mass Spectrom; 2020 Aug; 34 Suppl 2():e8713. PubMed ID: 31887235 [TBL] [Abstract][Full Text] [Related]
36. Differential effects of thromboxane A2 synthase inhibition, singly or combined with thromboxane A2/prostaglandin endoperoxide receptor antagonism, on occlusive thrombosis elicited by endothelial cell injury or by deep vascular damage in canine coronary arteries. Vandeplassche G; Hemans C; Van de Water A; Xhonneux R; Wouters L; Van Ammel K; De Clerck F Circ Res; 1991 Aug; 69(2):313-24. PubMed ID: 1830517 [TBL] [Abstract][Full Text] [Related]
37. Thromboxane (Tx) A2 receptor blockade and TxA2 synthase inhibition alone and in combination: comparison of anti-aggregatory efficacy in human platelets. Watts IS; Wharton KA; White BP; Lumley P Br J Pharmacol; 1991 Feb; 102(2):497-505. PubMed ID: 1826620 [TBL] [Abstract][Full Text] [Related]
38. Thromboxane modulating agents. 3. 1H-imidazol-1-ylalkyl- and 3-pyridinylalkyl-substituted 3-[2-[(arylsulfonyl)amino]ethyl]benzenepropanoic acid derivatives as dual thromboxane synthase inhibitor/thromboxane receptor antagonists. Dickinson RP; Dack KN; Long CJ; Steele J J Med Chem; 1997 Oct; 40(21):3442-52. PubMed ID: 9341919 [TBL] [Abstract][Full Text] [Related]
39. Enantioseparation of tetrahydropalmatine and Tröger's base by molecularly imprinted monolith in capillary electrochromatography. Ou J; Dong J; Tian T; Hu J; Ye M; Zou H J Biochem Biophys Methods; 2007 Feb; 70(1):71-6. PubMed ID: 16978700 [TBL] [Abstract][Full Text] [Related]
40. Novel antiasthmatic agents with dual activities of thromboxane A2 synthetase inhibition and bronchodilation. VI. Indazole derivatives. Yamaguchi M; Maruyama N; Koga T; Kamei K; Akima M; Kuroki T; Hamana M; Ohi N Chem Pharm Bull (Tokyo); 1995 Feb; 43(2):332-4. PubMed ID: 7728936 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]